294 results on '"Koedel, U."'
Search Results
2. Diagnostic value of cerebrospinal fluid CXCL13 for acute Lyme neuroborreliosis. A systematic review and meta-analysis
3. Adjuvant non-bacteriolytic and anti-inflammatory combination therapy in pneumococcal meningitis: an investigation in a mouse model
4. Nachweis löslichen Fas-Rezeptors und -Liganden im Liquor zerebrospinalis HlV-infizierter Patienten
5. Detection of Brain Free Oxygen Radical Generated Photons in Vivo: Preliminary Results
6. Pharmacologic Interference with NF-κB Activation Attenuates Central Nervous System Complications in Experimental Pneumococcal Meningitis
7. Role of Peroxynitrite as a Mediator of Pathophysiological Alterations in Experimental Pneumococcal Meningitis
8. Severe cochlear inflammation and vestibular syndrome in an experimental model of Streptococcus suis infection in mice
9. Neuroinfectious diseases at a European neurological tertiary care center: one-third of patients require treatment in the neurological intensive care unit
10. Nitrogen and Oxygen Molecules in Meningitis-Associated Labyrinthitis and Hearing Impairment
11. Superoxide Dismutase Inhibits Brain Oedema Formation in Experimental Pneumococcal Meningitis
12. N-Acetyl-L-Cystein bei bakterieller Meningitis: Eine zukünftige adjuvante Therapieoption?
13. Zyktokin CXCL13: Ein früher Liquormarker für die Neuroborreliose?
14. A role for the urokinase-type plasminogen activator system in amyotrophic lateral sclerosis
15. CXCL11 is involved in leucocyte recruitment to the central nervous system in neuroborreliosis
16. Evaluation of CSF Glial Fibrillary Acidic Protein (GFAP) as a Putative Marker for HIV-Associated Dementia
17. Streptococcus pneumoniae meningitis.
18. Role of S100A8 and S100A9 in leukocyte recruitment in trauma-induced inflammation in vivo: 179
19. Pathogenesis and pathophysiology: potential adjunctive therapies: S119
20. Vascular endothelial growth factor (VEGF) is increased in serum, but not in cerebrospinal fluid in HIV associated CNS diseases
21. Increased serum concentrations of tissue plasminogen activator correlate with an adverse clinical outcome in patients with bacterial meningitis
22. Pneumococcal meningitis in the rat: evaluation of peroxynitrite scavengers for adjunctive therapy
23. Failure of alpha-melanocyte stimulating hormone to attenuate cerebral complications in experimental pneumococcal meningitis
24. Reactive nitrogen species contribute to blood–labyrinth barrier disruption in suppurative labyrinthitis complicating experimental pneumococcal meningitis in the rat
25. Bivariate random effects meta-analysis assessing test accuracy when using the cerebrospinal fluid CXCL13 for diagnosis of acute Lyme neuroborreliosis
26. Protective Effect of a 21-Aminosteroid during Experimental Pneumococcal Meningitis
27. Microvascular Changes during the Early Phase of Experimental Bacterial Meningitis
28. Human immunodeficiency virus type-1 Nef protein induces blood–brain barrier disruption in the rat: role of matrix metalloproteinase-9
29. Superoxide production by primary rat cerebral endothelial cells in response to pneumococci
30. Changes of Intracranial Pressure in a Rat Meningitis Model
31. Inhibition of meningitis-associated neutrophil apoptosis by TNF- depends on functional PI3-kinase in monocytes
32. Der terminale Komplementkomplex ist für die Ausbildung einer suffizienten Immunantwort gegen Streptococcus pneumoniae im ZNS notwendig
33. Das Chemokin CXCL13 als Biomarker für die Neuroborreliose
34. Etablierung eines Meningitis-Modells für das Meerschweinchen nach Cochlea Implantation
35. Bacterial meningitis: the role of transforming growth factor-Beta in innate immunity and secondary brain damage
36. TGFbeta receptor II gene deletion in leucocytes prevents cerebral vasculitis in bacterial meningitis
37. A prospective study on the role of CXCL13 in Lyme neuroborreliosis
38. Therapy of community-acquired acute bacterial meningitis: the clock is running
39. Akute bakterielle Meningitis: Neues aus Forschung und Klinik
40. Der terminale Komplementkomplex ist für die Ausbildung einer suffizienten Immunantwort gegen Streptococcus pneumoniae im ZNS notwendig
41. Nitrogen and Oxygen Molecules in Meningitis-Associated Labyrinthitis and Hearing Impairment
42. Das Chemokin CXCL13 als Biomarker für die Neuroborreliose
43. Zyktokin CXCL13
44. The chemokine CXCL13 (BLC): A putative diagnostic marker for neuroborreliosis
45. Evaluation of cerebrospinal fluid uPA, PAI-1, and soluble uPAR levels in HIV-infected patients
46. Urate Oxidation in CSF and Blood of Patients with Inflammatory Disorders of the Nervous System
47. Role of the urokinase plasminogen activator system in patients with bacterial meningitis
48. Oxidative stress in bacterial meningitis in humans
49. Protective Effect of a 21-Aminosteroid during Experimental Pneumococcal Meningitis
50. Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.